Bcl-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin
- 31 December 2002
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 38 (8) , 752-756
- https://doi.org/10.1016/s1368-8375(02)00047-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Mechanisms of mitochondrial membrane permeabilizationCell Death & Differentiation, 2000
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI Journal of the National Cancer Institute, 2000
- Cleavage of Bax-α and Bcl-xL during carboplatin-mediated apoptosis in squamous cell carcinoma cell lineOral Oncology, 2000
- The Bcl-2 Protein FamilyExperimental Cell Research, 2000
- BCL-2 family members and the mitochondria in apoptosisGenes & Development, 1999
- Oral Chemotherapy in Head and Neck CancerDrugs, 1999
- Bcl-2 family proteinsOncogene, 1998
- Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of ApoptosisScience, 1998
- Cisplatin/Carboplatin Therapy in Non-Small Cell Lung CancerOncology, 1992
- Mechanisms of resistance to cisplatinPublished by Springer Nature ,1991